Mars, PA, United States of America

Kiflai Bein

This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiflai Bein. Retrieved from https://idiyas.com/inventor/kiflai-bein-hd113wpn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kiflai Bein: Innovator in Antidote Development

Introduction

Kiflai Bein is a notable inventor based in Mars, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing antidotes against organophosphorus nerve agents. His work is crucial in addressing the dangers posed by chemical agents and pesticides.

Latest Patents

Kiflai Bein holds 1 patent for his invention titled "Analogs of 2-pralidoxime as antidotes against organophosphorus nerve agents." This patent provides compounds that are useful in treating exposure to organophosphorus compounds, such as nerve agents and pesticides. The invention includes pharmaceutical compositions and dosage forms that comprise these compounds, as well as methods for treating patients exposed to such harmful agents.

Career Highlights

Kiflai Bein is affiliated with the University of Pittsburgh, where he continues to advance research in the field of antidote development. His innovative work has the potential to save lives by providing effective treatments for those exposed to dangerous chemicals.

Collaborations

Kiflai has collaborated with esteemed colleagues, including James Proviano Burrows and Kazunori Koide, to further enhance the impact of his research and inventions.

Conclusion

Kiflai Bein's contributions to the development of antidotes against organophosphorus nerve agents highlight his importance as an inventor in the pharmaceutical field. His work not only showcases innovation but also emphasizes the critical need for effective treatments in emergency situations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…